Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
beta-Catenin promotes epithelial architecture by forming cell surface complexes with E-cadherin and also interacts with TCF/LEF-1 in the nucleus to control gene expression. By DNA transfection, we overexpressed beta-catenin and/or LEF-1 in NIH 3T3 fibroblasts, corneal fibroblasts, corneal epithelia, uveal melanoma cells, and several carcinoma cell lines. In all cases (with or without LEF-1), the abundant exogenous beta-catenin localizes to the nucleus and forms distinct nuclear aggregates that are not associated with DNA. Surprisingly, we found that with time (5-8 d after transfection) cells overexpressing beta-catenin all undergo apoptosis. LEF-1 does not need to be present. Moreover, LEF-1 overexpression in the absence of exogenous beta-catenin does not induce apoptosis, even though some endogenous beta-catenin moves with the exogenous LEF-1 into the nucleus. TOPFLASH/FOPFLASH reporter assays showed that full-length beta-catenin is able to induce LEF-1-dependent transactivation, whereas Arm beta-catenin totally abolishes the transactivating function. However, Arm beta-catenin, containing deletions of known LEF-1-transactivating domains, has the same apoptotic effects as full-length beta-catenin. Overexpressed beta-catenin also induces apoptosis in cells transfected with nuclear localization signal-deleted LEF-1 that localizes only in the cytoplasm. Thus, the apoptotic effects of overexpressed exogenous beta-catenin do not rely on its transactivating function with nuclear LEF-1. Overexpressed delta-catenin, containing 10 Arm repeats, induces only minor apoptosis, suggesting that the major apoptotic effect may be due to domains specific to beta-catenin as well as to Arm repeats. The absence of
p53
, Rb, cyclin D1, or
E2F1
does not affect the apoptotic effect of overexpressed beta-catenin, but Bcl-x(L) reduces it. We hypothesize that in vivo apoptosis of cells overexpressing beta-catenin might be a physiological mechanism to eliminate them from the population.
...
PMID:Overexpression of beta-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators. 1102 52
We describe temporal and genetic analyses of partially rescued Rb mutant fetuses, mgRb:Rb-/-, that survive to birth and reveal specific defects in skeletal muscle differentiation. We show that in the absence of Rb, these fetuses exhibit increased apoptosis, bona fide endoreduplication, and incomplete differentiation throughout terminal myogenesis. These defects were further augmented in composite mutant fetuses, mgRb:Rb-/-:p21-/-, lacking both Rb and the cyclin-dependent kinase inhibitor p21(Waf1/Cip1). Although
E2F1
and
p53
mediate ectopic DNA synthesis and cell death in several tissues in Rb mutant embryos, both endoreduplication and apoptosis persisted in mgRb:Rb-/-:
E2F1
-/- and mgRb:Rb-/-:
p53
-/- compound mutant muscles. Thus, combined inactivation of Rb and p21(Waf1/Cip1) augments endoreduplication and apoptosis, whereas
E2F1
and
p53
are dispensable during aberrant myogenesis in Rb-deficient fetuses.
...
PMID:E2F1 and p53 are dispensable, whereas p21(Waf1/Cip1) cooperates with Rb to restrict endoreduplication and apoptosis during skeletal myogenesis. 1107 74
Most human cancers harbour aberrations of cell-cycle control, which result in deregulated activity of the E2F transcription factors with concomitant enhanced cell-cycle progression. Oncogenic signalling by
E2F1
has recently been linked to stabilization and activation of the tumour suppressor
p53
(refs 1,3,4). The p73 protein shares substantial sequence homology and functional similarity with
p53
(refs 5-7 ). Hence, several previously considered
p53
-independent cellular activities may be attributable to p73. Here we provide evidence that
E2F1
directly activates transcription of TP73, leading to activation of
p53
-responsive target genes and apoptosis. Disruption of p73 function by a tumour-derived
p53
mutant reduced
E2F1
-mediated apoptosis. Thus, p73 activation by deregulated
E2F1
activity might constitute a
p53
-independent, anti-tumorigenic safeguard mechanism.
...
PMID:Role of the p53-homologue p73 in E2F1-induced apoptosis. 1110 28
The identification of upstream pathways that signal to TP73 is crucial for understanding the biological role of this gene. Since some evidence suggests that TP73 might play a role in tumorigenesis, we asked whether oncogenes can induce and activate endogenous TP73. Here, we show that endogenous p73 alpha and beta proteins are up-regulated in
p53
-deficient tumor cells in response to overexpressed
E2F1
, c-Myc, and E1A.
E2F1
, c-Myc, and E1A-mediated p73 up-regulation leads to activation of the p73 transcription function, as shown by p73-responsive reporter activity and by induction of known endogenous p73 target gene products such as p21 and HDM2. Importantly,
E2F1
-, c-Myc-, and E1A-mediated activation of endogenous p73 induces apoptosis in SaOs-2 cells. Conversely, inactivation of p73 by a dominant negative p73 inhibitor (p73DD), but not by a mutant p73DD, inhibits oncogene-induced apoptosis. These data show that oncogenes can signal to TP73 in vivo. Moreover, in the absence of
p53
, oncogenes may enlist p73 to induce apoptosis in tumor cells.
...
PMID:Oncogenes induce and activate endogenous p73 protein. 1111 95
The retinoblastoma tumor suppressor, Rb, is a transcription cofactor that controls cell proliferation, survival and differentiation. Mutant mouse embryos lacking Rb exhibit ectopic proliferation and apoptosis that are mediated in some tissues by
E2F1
, a major partner of Rb, and by the
p53 tumor suppressor
. Whether
E2F1
and
p53
also mediate the differentiation defects in Rb mutant embryos is, however, not clear. Here we show that partially rescued mgRb:Rb-/- mutant fetuses exhibit ectopic lens epithelial cell proliferation, apoptosis and severe cataract. The abnormal cell proliferation and apoptosis were significantly suppressed in the lens of compound mutant fetuses lacking both Rb and
E2F1
at embryonic day (E) E15.5. Interestingly however, at E18.5, only ectopic proliferation, not apoptosis, was dramatically reduced in mgRb:Rb-/-:
E2F1
-/- lenses. In contrast,
p53
did not exert such a stage-specific effect and apoptosis was invariably suppressed in mgRb:Rb-/-:
p53
-/- composite mutant lenses throughout embryogenesis. Using RT-PCR and in situ hybridization analyses, we identified a subset of lens specific genes, most notably the late differentiation marker filensin, which were not properly induced during lens development in mgRb:Rb-/-fetuses. Remarkably, despite the inhibition of cell proliferation and apoptosis, the degeneration of lens fibers and aberrant expression of filensin were only marginally corrected in mgRb:Rb-/-:
E2F1
-/- fetuses at E15.5 but not at all at E18.5 or in mgRb:Rb-/-:
p53
-/mutant fetuses. Thus, inactivation of
E2F1
reduces ectopic cell proliferation and stage-specific
p53
-dependent apoptosis but does not rescue the differentiation defects associated with loss of Rb during lens development.
...
PMID:E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses. 1114 59
Increased expression of neurotrophins (e.g., NGF, BDNF) and chemokines (e.g., RANTES) has been observed in neurodegenerative diseases. We examined the effect of these factors on intracellular signaling cascades inducing cell cycle proteins
p53
, pRb, and
E2F1
in human fetal mixed neuronal and glial cells. Comparing neurotrophin- and chemokine-treated cultures with untreated controls showed altered subcellular localization and expression of hyperphosphorylated retinoblastoma protein (ppRb),
E2F1
, and
p53
. Using immunofluorescent laser confocal microscopy,
E2F1
and ppRb were detected exclusively in neuronal nuclei in control cultures while
p53
was cytoplasmic in astrocytes and nuclear in neurons. Following treatment with neurotrophins,
E2F1
and ppRb were observed in the cytoplasm of neurons, while
p53
was observed in both neuronal and astrocytic nuclei. Similar findings were observed following treatment with RANTES. Semiquantitative analysis using immunoblots showed an increase in the amount of phosphorylated pRb in treated cultures. Induction of cell cycle proteins may play a role in neurodegeneration associated with neurotrophin and chemokine stimulation.
...
PMID:Response of cell cycle proteins to neurotrophic factor and chemokine stimulation in human neuroglia. 1116 9
The E2F transcription factors are thought to be key downstream targets of the retinoblastoma protein (pRB) tumor suppressor. It is widely believed that
E2F1
, E2F2, and E2F3 can all activate cellular proliferation but that
E2F1
is the specific inducer of apoptosis. Here we show that the E2f3 mutation completely suppresses both the inappropriate proliferation and the
p53
-dependent apoptosis arising in the Rb mutant embryos. Through the analysis of Rb(-/-);E2f3(+/-) embryos, we have been able to separate E2F3's role in the induction of apoptosis from its ability to induce proliferation. Thus, contrary to the prevailing view of E2F action, E2F3 makes a major contribution to the apoptosis resulting from pRB loss.
...
PMID:E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. 1123 Jan 46
Hepatitis B virus X (HBx) protein is known as an oncogenic transactivator,
E2F1
as a positive regulator of the cell cycle, and pRb as a tumor suppressor. Here, we investigated the functional interactions of these proteins on the human Rb promoter. Interestingly, HBx transactivated the Rb promoter cooperatively with
E2F1
in HepG2 cells but not in HeLa cells, in which the functions of
p53
and pRb are inactive. Combinatorial cotransfection analyses in HepG2 cells showed that HBx overcame the inhibition of
E2F1
activity by pRb but not that by
p53
. Domain analysis showed that aa 47-70 and aa 117-133 of HBx are important for this effect. These results suggest that HBx could inhibit the pRb tumor suppressor and increase
E2F1
activity. Our data support the oncogenic potential of HBx, which may cause HBV-infected cells to grow continuously in the development of hepatocellular carcinoma.
...
PMID:Hepatitis B viral X protein overcomes inhibition of E2F1 activity by pRb on the human Rb gene promoter. 1124 64
p19ARF suppresses the growth of cells lacking
p53
through an unknown mechanism. p19ARF was found to complex with transcription factors
E2F1
, -2, and -3. Levels of endogenous or ectopically expressed
E2F1
, -2, and -3, but not E2F6, were reduced after synthesis of p19ARF, through a mechanism involving increased turnover. p19ARF-induced degradation of
E2F1
depended on a functional proteasome, and
E2F1
was relocalized to nucleoli when coexpressed with p19ARF. Consistent with reduced levels of
E2F1
and E2F3, the proliferation of cells defective for
p53
function was suppressed by p19ARF, and the effect was partially reversed by ectopic overexpression of
E2F1
. These results suggest a broader role for p19ARF as a tumor suppressor, in which targeting of certain E2F species may cooperate with stimulation of the
p53
pathway to counteract oncogenic growth signals.
...
PMID:p19ARF targets certain E2F species for degradation. 1127 64
Glioma cell lines show variable responses to radiation in a manner influenced by their
p53
status. Irradiation of glioma cell lines does not generally induce apoptosis. When wild-type
p53
is present, these cells undergo a G1 arrest that is closely associated with increased radiosensitivity as measured by clonogenic survival. Previously, others have shown that dysregulated overexpression of
E2F1
induces apoptosis in cell lines with either functional or inactivated
p53
. We found that regardless of
p53
status, apoptosis induced by overexpression of
E2F1
in glioma cell lines was further enhanced by treatment with ionizing radiation. BAX induction did not follow
E2F1
overexpression or irradiation in the glioma cell lines tested. Thus, the apoptotic response of glioma-derived cells to irradiation can be enhanced by
E2F1
by a mechanism that does not involve the induction of BAX.
...
PMID:Overexpression of E2F1 in glioma-derived cell lines induces a p53-independent apoptosis that is further enhanced by ionizing radiation. 1130 49
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>